Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 8,816 | 2,507 | 3,357 | 3,982 | 6,127 |
| Gross Profit | 8,816 | 2,507 | 3,357 | 3,982 | 6,127 |
| Operating Expenses | 37,521 | 17,494 | 40,023 | 44,205 | 52,639 |
| Operating Income | -28,705 | -14,987 | -36,666 | -40,223 | -46,512 |
| Interest Expense | 3,403 | 3,403 | 3,403 | 3,403 | 3,403 |
| Other Income | 278 | 347 | 466 | 408 | 581 |
| Pre-tax Income | -31,830 | -18,043 | -39,603 | -43,218 | -49,334 |
| Net Income Continuous | -31,830 | -18,043 | -39,603 | -43,218 | -49,334 |
| Net Income | $-31,830 | $-18,043 | $-39,603 | $-43,218 | $-49,334 |
| EPS Basic Total Ops | -0.97 | -0.74 | -1.69 | -2.11 | -2.49 |
| EPS Basic Continuous Ops | -0.96 | -0.74 | -1.69 | -2.11 | -2.54 |
| EPS Diluted Total Ops | -0.97 | -0.74 | -1.69 | -2.11 | -2.49 |
| EPS Diluted Continuous Ops | -0.96 | -0.74 | -1.69 | -2.11 | -2.54 |
| EBITDA(a) | $-28,841 | $-13,751 | $-34,385 | $-37,928 | $-44,174 |